USE OF NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF ANTIESTROGEN-RESISTANT BREAST CANCER

摘要

The use, respectively the method of use of neutralizing Prolactin receptor antibodies (PRLR antibodies) for the treatment and prevention of antiestrogen-resistant breast cancer is described. These antibodies can be combined with one ore more of several other cytotoxic agents, when used in treatment and prevention of antiestrogen- resistant breast cancer.